Patients receiving hemodialysis do not lose SARS-CoV-2 antibodies more rapidly than non-renal controls: a prospective cohort study

BACKGROUND: Patients with end-stage kidney disease receiving maintenance hemodialysis (HD) are at increased risk for mortality after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) compared with the general population. However, it is currently unknown whether the long-ter...

Descripción completa

Detalles Bibliográficos
Autores principales: Parshina, Ekaterina, Zulkarnaev, Alexey, Tolkach, Alexey, Ivanov, Andrey, Kislyy, Pavel, Gaipov, Abduzhappar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890585/
https://www.ncbi.nlm.nih.gov/pubmed/35220855
http://dx.doi.org/10.1080/0886022X.2022.2042310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890585/
https://www.ncbi.nlm.nih.gov/pubmed/35220855
http://dx.doi.org/10.1080/0886022X.2022.2042310

Ejemplares similares